FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010973471> ?p ?o ?g. }

• W2010973471 endingPage "165" @default.
• W2010973471 startingPage "156" @default.
• W2010973471 abstract "Immunotherapeutic strategies under consideration for type 1 diabetes include modification of the autoimmune response through antigen-specific routes. Administration of short peptides representing T cell epitopes targeted by patients with the disease represents one approach. This study evaluated safety and mechanistic outcomes during first-in-man intradermal administration of a human leucocyte antigen-DR4 (HLA-DR4)-restricted peptide epitope of proinsulin (C19-A3). This randomized, open-label study assessed two major theoretical risks of peptide immunotherapy, namely induction of allergic hypersensitivity and exacerbation of the proinflammatory autoimmune response, using clinical assessment and mechanistic assays in vitro. Patients with long-standing type 1 diabetes and HLA-DRB1*0401 genotype received 30 microg (n = 18) or 300 microg (n = 18) of peptide in three equal doses at 0, 1 and 2 months or no intervention (n = 12). Proinsulin peptide immunotherapy in the dosing regimen used is well tolerated and free from risk of systemic hypersensitivity and induction/reactivation of proinsulin-specific, proinflammatory T cells. Peptide-specific T cells secreting the immune suppressive cytokine interleukin (IL)-10 were observed at month 3 in four of 18 patients in the low-dose group (versus one of 12 in the control group; P = not significant). Mean IL-10 response to peptide in the low-dose group increased between 0 and 3 months (P = 0.05 after stimulation with 5 microM peptide in vitro) and then declined to baseline levels between 3 and 6 months (P = 0.01 at 10 microM peptide in vitro). These studies pave the way for future investigations in new-onset patients designed to examine whether proinsulin peptide immunotherapy has beneficial effects on markers of T cell autoimmunity and preservation of beta cell mass." @default.
• W2010973471 created "2016-06-24" @default.
• W2010973471 creator A5000786742 @default.
• W2010973471 creator A5013151434 @default.
• W2010973471 creator A5017791907 @default.
• W2010973471 creator A5019919427 @default.
• W2010973471 creator A5021263113 @default.
• W2010973471 creator A5021622442 @default.
• W2010973471 creator A5026184433 @default.
• W2010973471 creator A5026334006 @default.
• W2010973471 creator A5038020709 @default.
• W2010973471 creator A5053840112 @default.
• W2010973471 creator A5056183367 @default.
• W2010973471 creator A5069247087 @default.
• W2010973471 creator A5076162341 @default.
• W2010973471 date "2008-11-24" @default.
• W2010973471 modified "2023-10-16" @default.
• W2010973471 title "Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study" @default.
• W2010973471 cites W1523933450 @default.
• W2010973471 cites W1545313141 @default.
• W2010973471 cites W1979649698 @default.
• W2010973471 cites W1991664772 @default.
• W2010973471 cites W1993076646 @default.
• W2010973471 cites W2007193830 @default.
• W2010973471 cites W2007307182 @default.
• W2010973471 cites W2007523022 @default.
• W2010973471 cites W2012023401 @default.
• W2010973471 cites W2020690639 @default.
• W2010973471 cites W2024983647 @default.
• W2010973471 cites W2039166049 @default.
• W2010973471 cites W2042321461 @default.
• W2010973471 cites W2045385822 @default.
• W2010973471 cites W2048114019 @default.
• W2010973471 cites W2054698585 @default.
• W2010973471 cites W2054753856 @default.
• W2010973471 cites W2062451762 @default.
• W2010973471 cites W2065619967 @default.
• W2010973471 cites W2074463323 @default.
• W2010973471 cites W2089346000 @default.
• W2010973471 cites W2097649243 @default.
• W2010973471 cites W2111196174 @default.
• W2010973471 cites W2111457140 @default.
• W2010973471 cites W2119443577 @default.
• W2010973471 cites W2149513114 @default.
• W2010973471 cites W2149895222 @default.
• W2010973471 cites W2166685437 @default.
• W2010973471 cites W2776280 @default.
• W2010973471 cites W4233919530 @default.
• W2010973471 cites W614574849 @default.
• W2010973471 doi "https://doi.org/10.1111/j.1365-2249.2008.03814.x" @default.
• W2010973471 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2675245" @default.
• W2010973471 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19040615" @default.
• W2010973471 hasPublicationYear "2008" @default.
• W2010973471 type Work @default.
• W2010973471 sameAs 2010973471 @default.
• W2010973471 citedByCount "138" @default.
• W2010973471 countsByYear W20109734712012 @default.
• W2010973471 countsByYear W20109734712013 @default.
• W2010973471 countsByYear W20109734712014 @default.
• W2010973471 countsByYear W20109734712015 @default.
• W2010973471 countsByYear W20109734712016 @default.
• W2010973471 countsByYear W20109734712017 @default.
• W2010973471 countsByYear W20109734712018 @default.
• W2010973471 countsByYear W20109734712019 @default.
• W2010973471 countsByYear W20109734712020 @default.
• W2010973471 countsByYear W20109734712021 @default.
• W2010973471 countsByYear W20109734712022 @default.
• W2010973471 countsByYear W20109734712023 @default.
• W2010973471 crossrefType "journal-article" @default.
• W2010973471 hasAuthorship W2010973471A5000786742 @default.
• W2010973471 hasAuthorship W2010973471A5013151434 @default.
• W2010973471 hasAuthorship W2010973471A5017791907 @default.
• W2010973471 hasAuthorship W2010973471A5019919427 @default.
• W2010973471 hasAuthorship W2010973471A5021263113 @default.
• W2010973471 hasAuthorship W2010973471A5021622442 @default.
• W2010973471 hasAuthorship W2010973471A5026184433 @default.
• W2010973471 hasAuthorship W2010973471A5026334006 @default.
• W2010973471 hasAuthorship W2010973471A5038020709 @default.
• W2010973471 hasAuthorship W2010973471A5053840112 @default.
• W2010973471 hasAuthorship W2010973471A5056183367 @default.
• W2010973471 hasAuthorship W2010973471A5069247087 @default.
• W2010973471 hasAuthorship W2010973471A5076162341 @default.
• W2010973471 hasBestOaLocation W20109734712 @default.
• W2010973471 hasConcept C126322002 @default.
• W2010973471 hasConcept C147483822 @default.
• W2010973471 hasConcept C164027704 @default.
• W2010973471 hasConcept C195616568 @default.
• W2010973471 hasConcept C203014093 @default.
• W2010973471 hasConcept C2776914184 @default.
• W2010973471 hasConcept C2777701055 @default.
• W2010973471 hasConcept C2779306644 @default.
• W2010973471 hasConcept C2780868878 @default.
• W2010973471 hasConcept C71924100 @default.
• W2010973471 hasConcept C8891405 @default.
• W2010973471 hasConcept C90061646 @default.
• W2010973471 hasConceptScore W2010973471C126322002 @default.
• W2010973471 hasConceptScore W2010973471C147483822 @default.
• W2010973471 hasConceptScore W2010973471C164027704 @default.

• next